Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurobiol Dis. 2014 Sep;69:180-91. doi: 10.1016/j.nbd.2014.05.032. Epub 2014 Jun 2.

The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease.

Author information

1
Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Road, Storrs, CT 06269, USA; Department of Allied Health Sciences, University of Connecticut, 358 Mansfield Road, Storrs, CT 06269, USA.
2
Department of Biological Sciences, Ohio University, Athens, OH 45701, USA.
3
Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Road, Storrs, CT 06269, USA.
4
Department of Pathology, Case Western Reserve University, 2103 Cornell Rd, Cleveland, OH 44106, USA.
5
Department of Molecular and Cell Biology, University of Connecticut, 354 Mansfield Road, Storrs, CT 06269, USA; Department of Allied Health Sciences, University of Connecticut, 358 Mansfield Road, Storrs, CT 06269, USA. Electronic address: yih-woei.fridell@uconn.edu.

Abstract

Parkinson's disease (PD), caused by selective loss of dopaminergic (DA) neurons in the substantia nigra, is the most common movement disorder with no cure or effective treatment. Exposure to the mitochondrial complex I inhibitor rotenone recapitulates pathological hallmarks of PD in rodents and selective loss of DA neurons in Drosophila. However, mechanisms underlying rotenone toxicity are not completely resolved. We previously reported a neuroprotective effect of human uncoupling protein 2 (hUCP2) against rotenone toxicity in adult fly DA neurons. In the current study, we show that increased mitochondrial fusion is protective from rotenone toxicity whereas increased fission sensitizes the neurons to rotenone-induced cell loss in vivo. In primary DA neurons, rotenone-induced mitochondrial fragmentation and lethality is attenuated as the result of hucp2 expression. To test the idea that the neuroprotective mechanism of hUCP2 involves modulation of mitochondrial dynamics, we detect preserved mitochondrial network, mobility and fusion events in hucp2 expressing DA neurons exposed to rotenone. hucp2 expression also increases intracellular cAMP levels. Thus, we hypothesize that cAMP-dependent protein kinase (PKA) might be an effector that mediates hUCP2-associated neuroprotection against rotenone. Indeed, PKA inhibitors block preserved mitochondrial integrity, movement and cell survival in hucp2 expressing DA neurons exposed to rotenone. Taken together, we present strong evidence identifying a hUCP2-PKA axis that controls mitochondrial dynamics and survival in DA neurons exposed to rotenone implicating a novel therapeutic strategy in modifying the progression of PD pathogenesis.

PMID:
24965893
DOI:
10.1016/j.nbd.2014.05.032
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center